LIFECORE BIOMEDICAL, INC. Intangible Assets, Net (Excluding Goodwill)
LIFECORE BIOMEDICAL, INC. (LFCR) had Intangible Assets, Net (Excluding Goodwill) of $4.20 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2025-11-06
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $4.20M.
- 2025-05-25: Intangible Assets, Net (Excluding Goodwill) $4.20M.
- 2025-02-23: Intangible Assets, Net (Excluding Goodwill) $4.20M.
- 2024-11-24: Intangible Assets, Net (Excluding Goodwill) $4.20M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2025-09-30 | $4.20M 10-Q · filed 2025-11-06 |
| 2025-05-25 | $4.20M 10-Q · filed 2025-11-06 |
| 2025-02-23 | $4.20M 10-Q · filed 2025-04-03 |
| 2024-11-24 | $4.20M 10-Q · filed 2025-01-02 |
| 2024-08-25 | $4.20M 10-Q · filed 2024-10-04 |
| 2024-05-26 | $4.20M 10-K · filed 2025-08-07 |
| 2024-02-25 | $4.20M 10-Q · filed 2024-08-09 |
| 2023-11-26 | $4.20M 10-Q · filed 2024-08-09 |
| 2023-08-27 | $4.20M 10-Q · filed 2024-08-09 |
| 2023-05-28 | $4.20M 10-K · filed 2024-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |